1. Impact of Palliative Gastrectomy in Patients with Incurable Gastric Cancer
- Author
-
Ho Young Chung, Byunghyuk Yu, Seung Soo Lee, Ki Bum Park, Oh Kyoung Kwon, and Ji Yeon Park
- Subjects
medicine.medical_specialty ,Medicine (General) ,Multivariate analysis ,Palliative care ,medicine.medical_treatment ,Gastroenterology ,Article ,Metastasis ,neoplasm metastasis ,R5-920 ,Internal medicine ,Medicine ,Humans ,Neoplasm Staging ,Retrospective Studies ,stomach neoplasms ,palliative care ,business.industry ,Hazard ratio ,Cancer ,General Medicine ,medicine.disease ,Prognosis ,Primary tumor ,Confidence interval ,gastrectomy ,Survival Rate ,Lymphatic Metastasis ,Gastrectomy ,Female ,business - Abstract
Background and Objectives: The prognosis of metastatic or unresectable gastric cancer is dismal, and the benefits of the palliative resection of primary tumors with noncurative intent remain controversial. This study aimed to evaluate the impact of palliative gastrectomy (PG) on overall survival in gastric cancer patients. Materials and Methods: One hundred forty-eight gastric cancer patients who underwent PG or a nonresection (NR) procedure between January 2011 and 2017 were retrospectively reviewed to select and analyze clinicopathological factors that affected prognosis. Results: Fifty-five patients underwent primary tumor resection with palliative intent, and 93 underwent NR procedures owing to the presence of metastatic or unresectable disease. The PG group was younger and more female dominant. In the PG group, R1 and R2 resection were performed in two patients (3.6%) and 53 patients (96.4%), respectively. The PG group had a significantly longer median overall survival than the NR group (28.4 vs. 7.7 months, p <, 0.001). Multivariate analyses revealed that the overall survival was significantly better after palliative resection (hazard ratio (HR), 0.169, 95% confidence interval (CI), 0.088–0.324, p <, 0.001) in patients with American Society of Anesthesiologists Physical Status (ASA) scores ≤1 (HR, 0.506, 95% CI, 0.291–0.878, p = 0.015) and those who received postoperative chemotherapy (HR, 0.487, 95% CI, 0.296–0.799, p = 0.004). Among the patients undergoing palliative resection, the presence of <, 15 positive lymph nodes was the only significant predictor of better overall survival (HR, 0.329, 95% CI, 0.121–0.895, p = 0.030). Conclusions: PG might lead to the prolonged survival of certain patients with incurable gastric cancer, particularly those with less-extensive lymph-node metastasis.
- Published
- 2021